VAC7 Antibody

What is VAC7 and why is it important in research?

VAC7 (Vacuolar segregation protein 7) is a protein encoded by the VAC7 gene in yeast. It functions as a component of the PI(3,5)P2 regulatory complex, which includes ATG18, FIG4, FAB1, VAC14, and VAC7 . This protein plays a crucial role in regulating the synthesis and turnover of phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2). VAC7 is particularly significant in research because it activates FAB1 kinase during cellular stresses like hyperosmotic shock and can elevate levels of PtdIns(3,5)P2 even in the absence of VAC14 and FIG4 . Its direct involvement in vacuolar membrane scission, acidification, inheritance, and morphology makes it an important target for studying fundamental cellular processes in yeast models.

How do VAC7 antibodies differ from other vacuolar protein antibodies?

VAC7 antibodies are specifically designed to recognize and bind to the VAC7 protein, which has unique structural characteristics compared to other vacuolar proteins. Recent research has identified that VAC7 contains a lumenal domain in the LEA-2 (Late Embryogenesis Abundant-2) superfamily . This distinctive structural feature differentiates VAC7 antibodies from antibodies against other vacuolar proteins. While many antibody development protocols follow similar principles across targets, the specific epitopes targeted in VAC7 antibodies would recognize regions within the hydrophobic domain and the N-terminal portion of the LEA-2 domain, which have been identified through homology studies .

What experimental applications are VAC7 antibodies suitable for?

Based on common antibody applications similar to those used for other research antibodies, VAC7 antibodies would typically be suitable for:

• Western blotting for protein detection and quantification

• Immunoprecipitation to isolate VAC7 and associated protein complexes

• Immunofluorescence microscopy to visualize VAC7 localization

• Flow cytometry for analyzing VAC7 expression in individual cells

• Chromatin immunoprecipitation (ChIP) if studying interaction with DNA

When designing experiments with VAC7 antibodies, researchers should consider that VAC7 is a membrane-associated protein involved in the PI(3,5)P2 regulatory complex , which may influence experimental design and sample preparation methods.

What are the optimal fixation and permeabilization protocols for VAC7 immunostaining?

For effective VAC7 immunostaining, fixation and permeabilization protocols must account for VAC7's location in the vacuolar membrane. Based on its structural characteristics as a membrane protein with a single transmembrane helix (TMH) and lumenal domain , the following protocol is recommended:

• Fixation: Use 4% paraformaldehyde for 15-20 minutes at room temperature to preserve membrane structure.

• Permeabilization: Apply a gentle detergent like 0.1% Triton X-100 for 10 minutes or 0.5% saponin for 30 minutes.

• Blocking: Use 5% BSA or 10% normal serum from the secondary antibody host species for 1 hour.

• Primary antibody incubation: Dilute VAC7 antibody (typically 1:100 to 1:500, depending on antibody specificity) in blocking buffer and incubate overnight at 4°C.

• Secondary antibody: Use fluorophore-conjugated antibodies at manufacturer-recommended dilutions.

For yeast cells specifically, additional enzymatic digestion of the cell wall may be necessary prior to fixation, using enzymes like zymolyase or lyticase.

How can I validate the specificity of VAC7 antibodies?

Validating VAC7 antibody specificity is crucial for reliable experimental results. Implement these methodological approaches:

• Positive and negative controls:

  • Positive: Wild-type yeast expressing VAC7

  • Negative: VAC7 knockout/deletion strains

• Epitope blocking: Pre-incubate the antibody with purified VAC7 peptide before immunostaining; specific staining should be abolished.

• Cross-reactivity assessment: Test the antibody against Tag1, another LEA-2 family protein in yeast , to ensure it doesn't cross-react with homologous proteins.

• Multiple antibody validation: Use two antibodies targeting different epitopes of VAC7 to confirm consistent localization patterns.

• Western blot analysis: Confirm the antibody detects a band of the expected molecular weight (approximately 128 kDa for S. cerevisiae VAC7).

• Mass spectrometry validation: Perform immunoprecipitation followed by mass spectrometry to verify antibody specificity.

How can VAC7 antibodies be used to study the PI(3,5)P2 regulatory complex dynamics?

VAC7 antibodies can provide valuable insights into the dynamics of the PI(3,5)P2 regulatory complex through several advanced methodological approaches:

• Co-immunoprecipitation (Co-IP): Use VAC7 antibodies to pull down the entire PI(3,5)P2 regulatory complex, followed by western blotting for other components (ATG18, FIG4, FAB1, VAC14) . This approach can identify:

  • Complex formation under different conditions

  • Changes in complex composition during stress responses

  • Post-translational modifications affecting complex assembly

• Proximity Ligation Assay (PLA): Combine VAC7 antibodies with antibodies against other complex components to visualize protein-protein interactions in situ, providing spatial information about complex assembly.

• Förster Resonance Energy Transfer (FRET): Use fluorophore-conjugated VAC7 antibodies in combination with labeled antibodies against other complex components to measure protein-protein interaction distances.

• Super-resolution microscopy: Employ techniques like STORM or PALM with VAC7 antibodies to visualize the nanoscale organization of the regulatory complex with precision beyond the diffraction limit.

• Live-cell dynamics: For studying temporal dynamics, develop cell-permeable VAC7 antibody fragments or nanobodies that can track VAC7 localization during cellular processes.

What controls should be included when studying VAC7's role during hyperosmotic shock?

When investigating VAC7's function during hyperosmotic shock responses, the following methodological controls are essential:

Include appropriate sample processing controls: fix all samples simultaneously, process in parallel, and image under identical settings to ensure valid comparisons across experimental conditions.

How can I detect structural changes in VAC7 during membrane scission events?

Detecting structural changes in VAC7 during membrane scission events requires sophisticated methodological approaches:

• Conformation-specific antibodies: Develop antibodies that specifically recognize active versus inactive conformations of VAC7, focusing on regions predicted to undergo structural changes based on homology to LEA-2 proteins .

• Limited proteolysis: Perform controlled protease digestion of VAC7 under native conditions during different stages of membrane scission, followed by detection with region-specific VAC7 antibodies. Changes in digestion patterns indicate conformational shifts.

• FRET-based sensors: Design antibody-based FRET pairs that bind to different regions of VAC7, allowing real-time monitoring of structural changes through changes in FRET efficiency.

• Hydrogen-deuterium exchange mass spectrometry (HDX-MS): Use VAC7 antibodies to immunoprecipitate the protein at different stages of membrane scission, then perform HDX-MS to identify regions with altered solvent accessibility, indicating structural rearrangements.

• Cryo-electron microscopy: Utilize VAC7 antibodies in conjunction with cryo-EM to stabilize and visualize different conformational states during membrane scission.

The combination of these approaches can reveal how VAC7's structure changes during its role in vacuolar membrane scission, providing insights into its mechanism of action.

Why might VAC7 antibodies show inconsistent staining patterns in immunofluorescence?

Inconsistent staining patterns with VAC7 antibodies may occur due to several methodological factors:

• Fixation-dependent epitope masking: VAC7's complex structure with a transmembrane domain and LEA-2 homology region makes it susceptible to fixation-induced conformational changes. Solution: Compare multiple fixation methods (paraformaldehyde, methanol, glutaraldehyde) to determine optimal epitope preservation.

• Cell wall interference in yeast: The yeast cell wall can block antibody penetration. Solution: Optimize spheroplasting protocols with different enzymatic digestions and incubation times.

• VAC7 dynamism: VAC7's localization and conformation change during vacuolar functions . Solution: Synchronize cells and use time-course experiments to account for temporal variation.

• Antibody specificity issues: VAC7 shares homology with other LEA-2 family proteins . Solution: Verify specificity through knockout controls and peptide competition assays.

• Detection threshold limitations: VAC7 expression levels may vary. Solution: Implement signal amplification methods like tyramide signal amplification (TSA) or use more sensitive detection systems.

• Sample preparation variability: Inconsistent sample handling can affect results. Solution: Standardize protocols and process experimental and control samples in parallel.

What approaches can resolve conflicting results between VAC7 antibody staining and functional assays?

When facing discrepancies between VAC7 antibody staining patterns and functional assay results, employ these methodological approaches to resolve conflicts:

• Comprehensive validation: Verify antibody specificity using multiple methods:

  • Genetic controls (VAC7 knockout)

  • Epitope mapping to confirm target regions

  • Western blot correlation with staining results

• Multi-method corroboration: Apply complementary detection methods:

  • Fluorescent protein tagging of VAC7

  • Proximity labeling approaches (BioID or APEX)

  • Live-cell imaging with fluorescent probes for PI(3,5)P2

• Functional-spatial correlation analysis: Design experiments that simultaneously measure:

  • VAC7 localization (antibody staining)

  • VAC7 function (PI(3,5)P2 levels or vacuole morphology)

  • Protein interactions (co-IP or proximity ligation)

• Condition-sensitive analysis: Test whether discrepancies are condition-dependent:

  • Vary osmotic conditions

  • Examine different growth phases

  • Test mutants affecting VAC7 regulation

• Domain-specific antibodies: Use multiple antibodies targeting different VAC7 domains to determine if conformational changes explain the discrepancies.

• Quantitative correlation: Perform rigorous quantification of staining intensity versus functional readouts across multiple experiments to identify statistical relationships that may not be visually obvious.

How can VAC7 antibodies be used to study evolutionary relationships with TMEM106B?

Recent research has uncovered an evolutionary relationship between yeast VAC7 and human TMEM106B, as both contain domains with homology to the LEA-2 superfamily . This unexpected connection opens new research avenues that can be explored using VAC7 antibodies:

• Epitope conservation mapping: Develop antibodies against conserved epitopes between VAC7 and TMEM106B to:

  • Perform comparative immunostaining across species

  • Identify structurally conserved functional domains

  • Create cross-species phylogenetic antibody panels

• Functional complementation studies: Use antibodies to verify proper expression and localization in:

  • Human TMEM106B expressed in Δvac7 yeast

  • Yeast VAC7 domains expressed in human cell lines

• Structural homology validation: Employ antibodies in structural biology approaches to:

  • Perform epitope mapping to confirm predicted structural similarities

  • Identify conformational similarities through antibody cross-reactivity patterns

  • Develop conformation-specific antibodies that recognize both proteins

• Co-evolutionary network identification: Use VAC7 antibodies in complex immunoprecipitation to:

  • Compare VAC7 and TMEM106B interaction partners

  • Identify conserved regulatory mechanisms

  • Map evolutionary preservation of function versus structure

This methodological approach can provide insights into fundamental biological questions about how membrane protein functions have evolved from yeast to humans, particularly in the context of vesicular trafficking and membrane dynamics.

What methodological advances are needed to better study the relationship between VAC7 and Tag1 in yeast?

The identification of Tag1 as a second LEA-2 family protein in yeast raises important questions about functional redundancy or specialization with VAC7. To advance this research area, several methodological improvements are needed:

• Differentially specific antibodies: Develop antibodies that can distinguish between the similar LEA-2 domains of VAC7 and Tag1, focusing on:

  • Unique epitopes in non-conserved regions

  • Conformation-specific epitopes that differ between proteins

  • Post-translational modification-specific antibodies

• Temporal-spatial resolution improvement: Create methodologies to simultaneously track both proteins:

  • Dual-color super-resolution microscopy with highly specific antibodies

  • Live-cell imaging approaches with minimal functional interference

  • Correlative light and electron microscopy to map precise subcellular localizations

• Functional intersection analysis: Design methods to distinguish overlapping versus distinct functions:

  • Sequential immunodepletion to separate protein pools

  • Proximity-dependent labeling to map unique versus shared interaction networks

  • Protein complementation assays to detect direct interactions

• Domain-specific function mapping: Develop antibodies against specific domains to:

  • Block individual functions while preserving others

  • Detect domain-specific conformational changes during different cellular processes

  • Map domain-specific protein interactions

• Quantitative co-localization techniques: Implement advanced co-localization analysis:

  • Pixel-by-pixel correlation analysis across different cellular conditions

  • 3D co-localization assessment throughout entire cells

  • Temporal correlation of localization patterns during stress responses

These methodological advances would help resolve the complex relationship between these two LEA-2 family proteins in yeast and provide insights into functional diversification within protein families.